← Back
Data updated: Mar 10, 2026
ELITE LABS INC
Cardiovascular
ELITE LABS INC is a generic drug manufacturer focused on Cardiovascular.
1997
Since
15
Drugs
-
Trials
401
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
ROPINIROLE HYDROCHLORIDE 2026-01-22
Labeling
ROPINIROLE HYDROCHLORIDE 2026-01-22
Labeling
METHADONE HYDROCHLORIDE 2026-01-22
Manufacturing (CMC)
OXYCODONE AND ACETAMINOPHEN 2026-01-12
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2026-01-08
Labeling
OXYCODONE AND ACETAMINOPHEN 2026-01-06
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2025-12-31
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2025-12-31
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2025-12-31
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2025-12-31
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (6)
Discontinued (9)
Company Info
- First Approval
- 1997-05-30
- Latest
- 2025-12-22
- Applications
- 22
FDA Sponsor Names
ELITE LABS INCELITE LABS